Search Results - "Panici, P. B."

Refine Results
  1. 1

    Role of magnetic resonance imaging in fetuses with mild or moderate ventriculomegaly in the era of fetal neurosonography: systematic review and meta‐analysis by Di Mascio, D., Sileo, F. G., Khalil, A., Rizzo, G., Persico, N., Brunelli, R., Giancotti, A., Panici, P. B., Acharya, G., D'Antonio, F.

    Published in Ultrasound in obstetrics & gynecology (01-08-2019)
    “…ABSTRACT Objectives To report the rate of additional central nervous system (CNS) anomalies detected exclusively on prenatal magnetic resonance imaging (MRI)…”
    Get full text
    Journal Article
  2. 2
  3. 3

    The effect of surgery for endometrioma on ovarian reserve evaluated by antral follicle count: a systematic review and meta-analysis by Muzii, Ludovico, Di Tucci, Chiara, Di Feliciantonio, Mara, Marchetti, Claudia, Perniola, Giorgia, Panici, Pierluigi Benedetti

    Published in Human reproduction (Oxford) (10-10-2014)
    “…STUDY QUESTION Does surgical treatment of endometriomas impact on the ovarian reserve as evaluated with antral follicle count (AFC)? SUMMARY ANSWER This…”
    Get full text
    Journal Article
  4. 4
  5. 5

    PARP inhibition: A promising therapeutic target in ovarian cancer by Musella, A, Marchetti, C, Gasparri, M L, Salerno, L, Casorelli, A, Domenici, L, Imperiale, L, Ruscito, I, Abdul Halim, T, Palaia, I, Di Donato, V, Pecorini, F, Monti, M, Muzii, L, Panici, P B

    “…Ovarian cancer is burdened by the highest mortality rate among gynecological cancers. Gold standard is represented by the association of platinum-taxane -based…”
    Get more information
    Journal Article
  6. 6

    Management of hydrosalpinx before IVF: A literature review by D'Arpe, S., Franceschetti, S., Caccetta, J., Pietrangeli, D., Muzii, L., Panici, P. B.

    Published in Journal of obstetrics and gynaecology (18-08-2015)
    “…Hydrosalpinx has a detrimental effect on the outcome of in vitro fertilization (IVF). Surgical intervention such as salpingectomy or tubal occlusion before IVF…”
    Get full text
    Journal Article
  7. 7

    Quercetin potentiates the effect of Adriamycin in a multidrug-resistant MCF-7 human breast-cancer cell line : P-glycoprotein as a possible target by SCAMBIA, G, RANELLETTI, F. O, MANCUSO, S, PANICI, P. B, DE VINCENZO, R, BONANNO, G, FERRANDINA, G, PIANTELLI, M, BUSSA, S, RUMI, C, CIANFRIGLIA, M

    Published in Cancer chemotherapy and pharmacology (01-11-1994)
    “…This study demonstrates that the flavonoid quercetin (Q), a plant-derived compound with low toxicity in vivo, greatly potentiates the growth-inhibitory…”
    Get full text
    Journal Article
  8. 8

    Inhibitory effect of quercetin on OVCA 433 cells and presence of type II oestrogen binding sites in primary ovarian tumours and cultured cells by SCAMBIA, G, RANELLETTI, F. O, PANICI, P. B, PIANTELLI, M, BONANNO, G, DE VINCENZO, R, FERRANDINA, G, RUMI, C, LAROCCA, L. M, MANCUSO, S

    Published in British journal of cancer (01-12-1990)
    “…We investigated the effect of the flavonoid quercetin (Q) on the proliferation of the ovarian cancer cell line OVCA 433. Growth experiments demonstrated that Q…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Human B-cell immune response to the polymorphic epithelial mucin by RUGHETTI, A, TURCHI, V, GHETTI, C. A, SCAMBIA, G, PANICI, P. B, RONCUCCI, G, MANCUSO, S, FRATI, L, NUTI, M

    Published in Cancer research (Chicago, Ill.) (01-06-1993)
    “…Human antibodies generated by Epstein-Barr virus immortalized B-cells from tumor-draining lymph nodes of an ovarian cancer patient were screened for reactivity…”
    Get full text
    Journal Article
  11. 11

    Interleukin-6 serum levels in patients with gynecological tumors by Scambia, G, Testa, U, Panici, P B, Martucci, R, Foti, E, Petrini, M, Amoroso, M, Masciullo, V, Peschle, C, Mancuso, S

    Published in International journal of cancer (01-05-1994)
    “…Serum levels of IL-6 were evaluated in a large group of patients with benign or malignant gynecological tumors. The results obtained were correlated with the…”
    Get more information
    Journal Article
  12. 12

    Cervical cancer response to neoadjuvant therapy: MR imaging assessment by Manfredi, R, Maresca, G, Smaniotto, D, Greggi, S, Andrulli, D, Rabitti, C, Summaria, V, Valentini, A L, Panici, P B, Cellini, N, Marano, P

    Published in Radiology (01-12-1998)
    “…To determine the accuracy of magnetic resonance (MR) imaging in evaluating the invasive cervical carcinoma response to concurrent chemotherapy and radiation…”
    Get more information
    Journal Article
  13. 13

    In vitro effect of amifostine on haematopoietic progenitors exposed to carboplatin and non-alkylating antineoplastic drugs: haematoprotection acts as a drug-specific progenitor rescue by PIERELLI, L, SCAMBIA, G, FATTOROSSI, A, BONANNO, G, BATTAGLIA, A, PERILLO, A, MENICHELLA, G, BENEDETTI PANICI, P, LEONE, G, MANCUSO, S

    Published in British journal of cancer (01-10-1998)
    “…We evaluated the protective ability of amifostine on peripheral blood mononuclear cell (PBMC)-derived colony-forming unit (CFU) and PB CD34+ cells which were…”
    Get full text
    Journal Article
  14. 14

    Combined use of CA 125 and CA 15-3 in patients with endometrial carcinoma by Scambia, G, Gadducci, A, Panici, P B, Foti, E, Ferdeghini, M, Ferrandina, G, Amoroso, M, Castellani, C, Facchini, V, Mancuso, S

    Published in Gynecologic oncology (01-09-1994)
    “…Serum levels of CA 125 and CA 15-3 were measured in 148 patients with primary endometrial carcinoma. CA 125-positive levels were found in 33 and 22% of the…”
    Get more information
    Journal Article
  15. 15

    Quercetin induces type-II estrogen-binding sites in estrogen-receptor-negative (MDA-MB231) and estrogen-receptor-positive (MCF-7) human breast-cancer cell lines by Scambia, G, Ranelletti, F O, Panici, P B, Piantelli, M, De Vincenzo, R, Ferrandina, G, Bonanno, G, Capelli, A, Mancuso, S

    Published in International journal of cancer (28-05-1993)
    “…We show that flavonoids positively regulate type-II estrogen-binding site (type-II EBS) levels both in MCF-7 (ER-positive) and in MDA-MB231 (ER-negative)…”
    Get more information
    Journal Article
  16. 16

    Postoperative administration of monophasic combined oral contraceptives after laparoscopic treatment of ovarian endometriomas: A prospective, randomized trial by Muzii, Ludovico, Marana, Riccardo, Caruana, Paul, Catalano, Giovan Fiore, Margutti, Ferdinando, Panici, Pierluigi Benedetti

    “…Objective: We sought to evaluate the efficacy of postoperative administration of monophasic, combined, low-dose oral contraceptives on endometrioma recurrence…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Clinical significance of cathepsin D in primary ovarian cancer by Scambia, G, Panici, P B, Ferrandina, G, Salerno, G, D'Agostino, G, Distefano, M, de Vincenzo, R, Ercoli, A, Mancuso, S

    Published in European journal of cancer (1990) (1994)
    “…Cathepsin D (Cath D) levels were assayed in a prospective series of 72 patients with primary ovarian carcinoma, by using an immunoradiometric assay. Cath D…”
    Get more information
    Journal Article
  19. 19

    Expression of ras oncogene p21 protein in normal and neoplastic laryngeal tissues : correlation with histopathological features and epidermal growth factor receptors by SCAMBIA, G, CATOZZI, L, MAURIZI, M, PANICI, P. B, FERRANDINA, G, ALMADORI, G, PALUDETTI, G, CADONI, G, DISTEFANO, M, PIFFANELLI, A, MANCUSO, S

    Published in British journal of cancer (01-06-1994)
    “…Western blotting analysis of the p21 ras oncoprotein was performed in seven normal laryngeal mucosa specimens and 43 primary laryngeal cancers. Varying p21…”
    Get full text
    Conference Proceeding Journal Article
  20. 20

    The value of squamous cell carcinoma antigen in patients with locally advanced cervical cancer undergoing neoadjuvant chemotherapy by Scambia, G, Panici, P B, Baiocchi, G, Amoroso, M, Foti, E, Greggi, S, Mancuso, S

    “…Serum levels of squamous cell carcinoma antigen were measured in 688 samples from 119 patients with cervical cancer. Ninety-seven patients had primary tumors…”
    Get more information
    Journal Article